Xander Pharmaceuticals Private Limited

Pharmaceutical company manufacturing, selling, distributing, exporting, and importing medicines and related products.

2012 | Malappuram, Kerala (India) | Active
Last Updated:

Xander Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 2.00 M
  • Company Age 13 Year, 2 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth %
  • Profit Growth -4.02%
  • Ebitda -11.21%
  • Net Worth -2.93%
  • Total Assets -5.66%

About Xander Pharmaceuticals

Xander Pharmaceuticals Private Limited (XPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2012 and has a history of 13 years and two months. Its registered office is in Malappuram, Kerala, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.

Raghunath Kolayambarampath and Kozhappilly Kutty serve as directors at the Company.

Company Details

  • Location

    Malappuram, Kerala, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24233KL2012PTC030714

  • Company No.

    030714

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    09 Mar 2012

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ernakulam

Industry

Pharma
Company report

Xander Pharmaceuticals Private Limited

Explore comprehensive data for Xander Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Xander Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Kozhappilly Kutty Country flag representing In Director 10-May-2024Current
Raghunath Kolayambarampath Country flag representing In Whole-Time Director 05-Apr-2014Current

Financial Performance of Xander Pharmaceuticals.

Xander Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 4.02% decrease in profit. The company's net worth dipped by a decrease of 2.93%.

Xander Pharmaceuticals revenue growth over time
Xander Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-5.66%
Profit or Loss
-4.02%
Net Worth
-2.93%
EBITDA
-11.21%

What is the Ownership and Shareholding Structure of Xander Pharmaceuticals?

Unlock access to Xander Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Xander Pharmaceuticals?

Unlock and access historical data on people associated with Xander Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Xander Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Xander Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xander Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Xander Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Kozhappilly Narayanan Kutty was appointed as a Director was appointed as a Director on 10 May 2024 & has been associated with this company since 1 year 15 days .

  • Annual General Meeting

    Xander Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Xander Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam.

  • Director Appointment

    Raghunath Kolayambarampath was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 05 Apr 2014 & has been associated with this company since 11 years 1 month .

  • Company Incorporation

    Xander Pharmaceuticals Private Limited was registered on 09 Mar 2012 with Roc Ernakulam & aged 13 years 2 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Xander Pharmaceuticals Private Limited?

    Xander Pharmaceuticals Private Limited was incorporated on 09 Mar 2012.

  • What is authorized share capital and paid-up capital of Xander Pharmaceuticals Private Limited?

    The authorized share capital of Xander Pharmaceuticals Private Limited is ₹ 5.00 M and paid-up capital is ₹ 2.00 M.

  • Who are the current board members & directors of Xander Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Xander Pharmaceuticals Private Limited.

    • Raghunath Kolayambarampath
    • Kozhappilly Narayanan Kutty

  • What is the registered address of Xander Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Xander Pharmaceuticals Private Limited is 2/530 C-D-E Anamangad P.O. Perinthalmanna, Malappuram India, Perintalmanna, Kerala, 679357.

  • What is the corporate identification number (CIN) and company number of Xander Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Xander Pharmaceuticals Private Limited is U24233KL2012PTC030714 and the company number is 030714 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Xander Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Xander Pharmaceuticals Private Limited has experienced an downturn of -2.93%.

  • When was the last Balance Sheet of Xander Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Xander Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors